Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PROC”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT00014859
What this trial is testing

Epidemiology of Surfactant Protein-B Deficiency

Who this might be right for
Lung DiseasesRespiratory Distress Syndrome, NewbornPulmonary Surfactant+1 more
Washington University School of Medicine 5,176
Testing effectiveness (Phase 2)Looking for participantsNCT06303505
What this trial is testing

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Who this might be right for
Ovarian CancerNon-small Cell Lung Cancer
Tubulis GmbH 250
Early research (Phase 1)Looking for participantsNCT07470853
What this trial is testing

MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Who this might be right for
PROCPlatinum Resistant Ovarian CancerEndometrial Cancer
Whitehawk Therapeutics, Inc. 265
Not applicableStudy completedNCT00943267
What this trial is testing

Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)

Who this might be right for
PneumoniaLipopolysaccharides
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 52
Large-scale testing (Phase 3)WithdrawnNCT05484154
What this trial is testing

Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke

Who this might be right for
Ischemic Stroke
ZZ Biotech, LLC
Large-scale testing (Phase 3)Active Not RecruitingNCT06619236
What this trial is testing

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 530
Testing effectiveness (Phase 2)Ended earlyNCT05243524
What this trial is testing

Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian Cancer
ImmunoVaccine Technologies, Inc. (IMV Inc.) 16
Testing effectiveness (Phase 2)Study completedNCT01411670
What this trial is testing

Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.

Who this might be right for
SepsisSeptic Shock
University of Roma La Sapienza 60
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Testing effectiveness (Phase 2)Study completedNCT05044871
What this trial is testing

Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tongji Hospital 108
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Study completedNCT03657043
What this trial is testing

Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Seagen Inc. 98
Large-scale testing (Phase 3)Not Yet RecruitingNCT07604766
What this trial is testing

An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 82
Large-scale testing (Phase 3)Looking for participantsNCT07546500
What this trial is testing

Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Who this might be right for
Ovarian Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 420
Not applicableStudy completedNCT00828243
What this trial is testing

Genetic Regulation of Surfactant Deficiency

Who this might be right for
Respiratory Distress Syndrome, Newborn
Washington University School of Medicine 525
Early research (Phase 1)Not Yet RecruitingNCT07462468
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer (PROC)
WestVac Biopharma Co., Ltd. 36
Not applicableStudy completedNCT00883597
What this trial is testing

Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation

Who this might be right for
Sepsis
Nova Scotia Health Authority 36
Not applicableUnknownNCT04324255
What this trial is testing

Von Willebrand Factor and Protein C Ratio in Graft Function After Liver Transplant

Who this might be right for
Liver Transplant; Complications
Asan Medical Center 1,199
Post-approval studies (Phase 4)Not Yet RecruitingNCT07075250
What this trial is testing

Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study

Who this might be right for
Platinum-resistant Ovarian Cancer (PROC)
Peking University People's Hospital 30
Not applicableUnknownNCT04535206
What this trial is testing

The Relationship Between the Lack of AT-Ⅲ, PC, PS Activity and PICC-related Thrombosis

Who this might be right for
Central Venous Catheter Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University 112
Load More Results